https://doi.org/10.4081/reumatismo.2013.75

Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis

Vol. 65 No. 2 (2013)
Submitted: 5 February 2013
Accepted: 19 March 2013
Published: 27 May 2013
Ulcerative colitis, Rheumatoid arthritis, Adalimumab.
Abstract Views: 2858
PDF: 851
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

G. Andrisani
Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
E. Gremese
Rheumatology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
L. Guidi
Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
A. Papa
Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
M. Marzo
Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
C. Felice
Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
D. Pugliese
Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
A. Armuzzi
alearmuzzi@yahoo.com
Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
Inflammatory bowel disease (IBD) is commonly associated with peripheral inflammatory arthritis, and it has been estimated that as many as 12% of IBD patients report these manifestations. However, rheumatoid arthritis (RA) is rarely associated with ulcerative colitis (UC). Among all the biological agents available, nine have been currently approved for the treatment of RA. Conversely, only Infliximab and recently Adalimumab have been approved for UC. In particular, the efficacy of Adalimumab in UC has been demonstrated by both recent randomized controlled trials and real-life studies. Moreover, Adalimumab is a well-established treatment for RA. Herein, we describe a patient with RA and UC treated successfully with ADA.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

None
G. Andrisani, Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome
Internal Medicine and Gastroenterology Unit
E. Gremese, Rheumatology Unit, Complesso Integrato Columbus, Catholic University, Rome
Rheumatology Unit

How to Cite

Andrisani, G., Gremese, E., Guidi, L., Papa, A., Marzo, M., Felice, C., … Armuzzi, A. (2013). Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis. Reumatismo, 65(2), 75–78. https://doi.org/10.4081/reumatismo.2013.75

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Similar Articles

<< < 29 30 31 32 33 34 35 36 > >> 

You may also start an advanced similarity search for this article.